Preemptive analgesia may improve post-op pain management in ACL reconstruction .
This report has been verified
by one or more authors of the
original publication.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(9):73 BMC Musculoskelet Disord. 2010 Oct 25;11:246102 patients scheduled to undergo arthroscopic ACL reconstruction were randomized to receive etoricoxib 120 mg, celecoxib 400 mg, or placebo, 1 hour prior to operative incision. During the 48 hour post-operative period, pain scores and additional analgesia requirements were recorded to evaluate analgesic efficacy of these two drugs. It was observed that the post-operative pain management at 8 hours was better achieved by using single preemptive dose of etoricoxib than celecoxib or a placebo.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Sì = 1
Incerto = 0,5
Non rilevante = 0
No = 0
La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.
2/4
Randomization
3/4
Outcome Measurements
4/4
Inclusion / Exclusion
4/4
Therapy Description
4/4
Statistics
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.
Perché questo studio era necessario ora?
Selective COX-2 inhibitors offer a pragmatic alternative to conventional NSAIDs and opiates for the relief of postoperative pain. Although both etoricoxib and celecoxib (selective COX-2 inhibitors), have shown to reduce post-operative pain, the comparative efficacy of these agents had not been studied. The current study aimed to investigate the superiority of one drug over the other in anterior cruciate ligament reconstruction surgery.
Qual era la domanda di ricerca principale?
Does etoricoxib or celecoxib offer the best efficacy as a single-dose preemptive analgesic for post-operative pain relief in patients undergoing arthroscopic ACL reconstruction?
- Postoperative mean pain satisfaction score between all three groups was similar on the VbAPS (Etoricoxib = 78.14, Celecoxib = 80.68, placebo = 72.22)
- Amount of paracetamol and fentanyl used, and the time to first dose of analgesic medication was similar in all groups (all p>0.05)
- Up to 8 hours post-op, the etoricoxib group had significantly less pain (p<0.05) (no differences in any other evaluation points)
- Number of adverse events was similar across all 3 groups. Only fever (p=0.005) and constipation (p=0.025) were significantly higher in the placebo group
- Mean blood loss in all groups was similar (p=0.663)
Che cosa devo ricordare di più?
Etoricoxib was a more effective pre-operative analgesic than celecoxib and placebo in controlling postoperative pain in patients undergoing arthroscopic ACL reconstruction. Etoricoxib and Celecoxib did not reduce analgesic consumption, or time to first analgesic use.
Come influenzerà l'assistenza ai miei pazienti?
In order to improve post-op pain management in patients undergoing arthroscopic ACL reconstruction, etoricoxib may be used as a preemptive analgesic. Larger studies are needed to validate these findings.
DISCLAIMER
Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.
0 di 4 articoli mensili GRATUITI sbloccati
